Herbert S B Baraf, MD: SEL-212 Novel Combination Therapy for Gout

SEL-212, an alternative to standard therapy that is administered once monthly, has proven to be particularly helpful for patients with severe gout, a historically underserved population.

Related Keywords

Herbert Sb Baraf ,Health Sciences ,National Institute Of Arthritis ,George Washington University School Of Medicine ,Clinical Professor ,George Washington University School ,Principal Investigator ,Combination Therapy ,Image Credit ,National Institute ,